Market Analysis: The global Pulmonary Drug Delivery Systems market was valued at approximately US$ 3,305 million in 2024 and is projected to reach around US$ 4,391 million by 2031, reflecting a CAGR of 4.2% during the forecast period from 2025 to 2031. The global pulmonary drug delivery systems market is witnessing consistent growth due to the increasing prevalence of respiratory...